Phase I-II

(zubada/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The agency continues to offer advice and take actions impacting the pharmaceutical and life-science industries during the pandemic.

(Image: Getty/wildpixel)

Immunai unveils map of human immune system

By Jenni Spinner

A research team including MIT, Harvard and Stanford researchers has raised $20m in seed funding for their effort to map out immune cells with machine learning.

(Image: Getty/gorodenkoff)

Avalere: FDA can impact COVID-era drug development

By Jenni Spinner

A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.

(Image: Getty/zubada)

This week's FDA COVID-19 actions and advice

By Jenni Spinner

The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.

(Image: Getty/ffrikretow)

Weekly FDA COVID-19 update

By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.

Follow us

Product Innovations